What a Trough Concentration Represents
A concentration result is meaningful only in relation to when it was collected. For a recurring dosing regimen, the trough is the lowest concentration in a dosing interval. In routine monitoring, the intended trough is commonly the concentration immediately before the next scheduled dose. That timing makes the result a practical measure of the low end of the concentration profile, but the word “predose” alone does not guarantee that a sample is a trough.
The dosing interval, written here as \(\tau\), is the scheduled time between successive doses. If a dose was given at time 0 and the next dose is due at time \(\tau\), the interval trough is the concentration just before that next dose, denoted \(C(\tau^-)\). The minus sign indicates the moment before the dose is administered; a sample taken after the dose is not a predose trough for that interval.
For example, if a patient takes a dose every 12 hours, a sample collected immediately before the next scheduled dose is intended to estimate the 12-hour trough. A sample collected 8 hours after the previous dose is not that interval’s trough, even if it is called “predose” in a note because the next dose is approaching. The relevant clock is elapsed time since the last administered dose, checked against the scheduled next dose.
Many clinical targets are defined for a repeating regimen and a stable concentration profile. In that setting, the trough is the low point of the repeating interval profile. If the regimen has recently changed or doses have not been taken as prescribed, a result may still be a correctly timed predose concentration but may not represent the trough expected under the intended recurring regimen.
When Does Predose Equal the Trough?
A predose sample is a good representation of the interval minimum when three conditions are met. First, the sample is taken immediately before the scheduled dose, with no intervening dose. Second, the interval has the intended duration: the prior dose and the upcoming dose are known and appropriately spaced. Third, the concentration profile has reached its minimum at the interval endpoint. The third condition is usually reasonable when the prior dose has been absorbed and the concentration is declining toward the next dose, but it should not be assumed for every formulation or clinical circumstance.
The concentration may not be declining throughout the interval. For instance, ongoing or delayed absorption can cause concentration to rise after a nominal predose time, and a prolonged input may change where the interval minimum occurs. A dose taken late, an unrecorded extra dose, or sampling after the scheduled dose can also make the reported timing inconsistent with the intended interval. In such cases, the result should be described by its actual sampling time rather than automatically labelled a trough.
A simple elimination model helps quantify how a sample taken before the interval endpoint differs from the endpoint concentration. Assume that after the relevant input is complete, concentration follows first-order elimination: the rate of concentration change is proportional to the concentration present. Let \(k_{\mathrm{el}}\) be the elimination rate constant, in inverse time units. Then
Separating variables and integrating from time \(t_1\) to \(t_2\) gives \(\ln\{C(t_2)/C(t_1)\}=-k_{\mathrm{el}}(t_2-t_1)\). If the elimination half-life is \(t_{1/2}=\ln(2)/k_{\mathrm{el}}\), the same relationship can be written in half-life form:
This relation applies only over a period with no relevant drug input and under the stated first-order elimination model. It can estimate a later concentration from an earlier one in that period, but it does not turn a mistimed sample into a directly observed trough. The estimate inherits the model assumptions and uncertainty in the times, concentration, and half-life.
Worked Interpretations Across Dosing Intervals
Worked Example: Checking a 12-Hour Predose Sample
Hypothetical case. A patient receives a dose every 12 hours, at 08:00 and 20:00. Assume the intended interval profile repeats, absorption is complete by 2 hours after the dose, and subsequent elimination is first-order with a half-life of 6 hours. The concentration at 2 hours after a dose is 12.0 mg/L. Estimate the concentration immediately before the next 08:00 dose, and decide what a sample collected at 07:59 would represent.
The interval is \(\tau=12\) hours. From the reference time of 2 hours after dosing to the interval endpoint at 12 hours, 10 hours elapse. The concentration estimate is
The first numerical approximation is the exponential factor rounded for display; the evaluated concentration is approximately 3.780 mg/L. A sample at 07:59 is one minute before the scheduled 08:00 dose and almost 12 hours after the prior 20:00 dose. Provided no dose was taken in between and the concentration is declining over this final period, it is a practical predose estimate of the 12-hour trough. The calculation predicts the endpoint concentration from the hypothetical 2-hour value; it is not a substitute for recording the actual sample time.
Worked Example: A 24-Hour Interval and a Later Reference Sample
Hypothetical case. A drug is administered every 24 hours. Under a first-order elimination assumption after absorption is complete, the concentration 8 hours after a dose is 18.0 mg/L, and the half-life is 18 hours. Estimate the concentration at 24 hours, immediately before the next scheduled dose.
The elapsed time from the reference sample to the interval endpoint is \(24-8=16\) hours. Therefore,
The predicted 24-hour concentration is approximately 9.721 mg/L. This is a model-based estimate of the daily trough, not a concentration directly measured at 24 hours. It is valid only if the dose timing is correct, no additional input occurs between 8 and 24 hours, and the assumed elimination model adequately describes that period. A measured sample collected immediately before the next dose would be the direct predose result for this interval.
Worked Example: Correcting a Sample Taken Before an 8-Hour Trough
Hypothetical case. A patient is scheduled to take a drug every 8 hours. A sample is collected 7 hours after the last dose, one hour before the next dose, and measures 4.20 mg/L. Assume no further input before the next dose and a first-order elimination half-life of 4 hours. Estimate the concentration at the scheduled 8-hour endpoint.
The sample is predose, but it is not at the end of the 8-hour interval. One hour of elimination remains. Thus,
Under the assumptions, the estimated interval-end concentration is approximately 3.532 mg/L. The measured value, 4.20 mg/L, is the concentration at 7 hours, not the 8-hour trough. This distinction matters when comparing results with a target defined specifically at the end of the dosing interval.
Interpreting and Troubleshooting a Trough
A trough target is meaningful only when the measured concentration and the target refer to comparable conditions. A result should be interpreted with the dose, interval, actual time of the last dose, time of the next scheduled dose, and time of sampling in view. For a regimen given every 8 hours, a concentration measured 7 hours after the last dose cannot be compared as though it were an 8-hour trough without an appropriate reason and method for doing so.
Troughs also have a specific role among exposure measures. They describe the low end of the concentration profile and can be useful when efficacy or toxicity is related to maintaining a minimum concentration. They do not, by themselves, describe the peak concentration or the total exposure over an interval. A peak target or an area-under-the-curve target addresses a different feature of exposure; the target should match the clinical question and the evidence supporting it.
| Question | What the result describes | Timing requirement |
|---|---|---|
| Is the interval minimum adequate? | Low concentration during the interval | At or near the interval endpoint, before the next dose |
| What is the high concentration after a dose? | Postdose peak or specified postdose concentration | At the defined postdose time |
| What is total exposure over an interval? | Concentration integrated over time | Requires an exposure measure over the interval |
Several clues suggest that a reported “trough” may not be interpretable as intended:
- The sample time is inconsistent with the prescribed interval or the documented dose time.
- The next dose was administered before the sample was collected.
- The concentration is unexpectedly higher than an earlier value despite a period assumed to have no input and declining elimination.
- Absorption may still be occurring, or another source of drug input has not been accounted for.
- The regimen has changed recently, doses have been missed or delayed, or the dose history is otherwise uncertain.
These findings do not prove that the laboratory result is wrong. They indicate that its timing or dosing context needs clarification before it is used as a trough-based target comparison.
Common Pitfall: Calling Every Predose Result a Trough
Incorrect reasoning: “The blood was drawn before a dose, so it must be the trough.” This overlooks how long it has been since the preceding dose and whether concentration was at its minimum at the sampling time.
Correction: Compare the sample time with both the preceding dose and the next scheduled dose. A sample collected just before the scheduled dose is the operational predose trough when the regimen and concentration profile support that interpretation. If it was collected earlier, it is a predose concentration at that elapsed time; any estimate of the endpoint requires explicit assumptions and a justified calculation.
A second mistake is treating an estimated trough as an exact observation. The first-order equation is useful for illustration and for justified predictions, but real profiles may depart from its assumptions. If the assumed half-life or the timing is inaccurate, the estimated endpoint can be inaccurate as well. Whenever possible, interpret the actual measured concentration at its actual time and keep model-based estimates distinct from measured values.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions.
- A dose is scheduled every 12 hours. A sample is collected 11 hours after the previous dose and before the next one. Is it an exact 12-hour trough? What information would be needed to estimate the interval-end value?
- A hypothetical drug has a half-life of 5 hours. A concentration of 8.00 mg/L is measured 5 hours after the dose, and the next scheduled dose is at 10 hours. Under first-order elimination with no further input, estimate the 10-hour concentration.
- Why might a sample collected immediately before the next scheduled dose fail to be the minimum concentration during the interval?
- For a drug dosed every 24 hours, what elapsed-time information is needed to decide whether a blood sample is a predose trough?
Solutions. (1) It is predose but was collected one hour before the scheduled interval endpoint, so it is not an exact 12-hour trough. To estimate the endpoint, one needs the measured concentration, the time difference, and a defensible elimination model and half-life; one must also know that no further input occurs. (2) Five hours elapse between the sample and the next dose, which is one half-life. Thus \(C(10)=8.00\times 2^{-5/5}=4.00\) mg/L. (3) Continued or delayed absorption, another source of input, or a concentration profile that has not reached its minimum by the scheduled dose time can make an earlier point lower. (4) The time since the last administered dose and the time until the next scheduled dose are needed, along with confirmation that no intervening dose was taken. A predose label without those times does not establish that the sample is the 24-hour interval minimum.